Showing results (41-50 of 143) with videos related to
Sort By:
Pageof 15
European Journal of Immunology|June 24, 2004
Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptorsMonika Gladow, Wolfgang Uckert, Thomas BlankensteinCurrent Opinion in Immunology|October 7, 2021
The role of CD4 T cells in rejection of solid tumorsLucia Poncette, Julia Bluhm, Thomas BlankensteinJournal for Immunotherapy of Cancer|February 23, 2023
Generation of TGFβR2(-1) neoantigen-specific HLA-DR4-restricted T cell receptors for cancer therapyNatalia Plewa, Lucia Poncette, Thomas BlankensteinJournal for Immunotherapy of Cancer|May 2, 2025
Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoireLeonie Rosenberger, Leo Hansmann, Vasiliki Anastasopoulou, et al.Blood|October 16, 2025
A CD22-Specific T-Cell Receptor Enables Effective Adoptive T-Cell Therapy for B-cell malignanciesSimone Rhein, Neşe Çakmak-Görür, Corinna Grunert, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
Dual T cell receptor expressing CD8+ T cells with tumor- and self-specificity can inhibit tumor growth without causing severe autoimmunityMonika Weinhold, Daniel Sommermeyer, Wolfgang Uckert, et al.Current Opinion in Immunology|March 3, 2015
Targeting cancer-specific mutations by T cell receptor gene therapyThomas Blankenstein, Matthias Leisegang, Wolfgang Uckert, et al.Cancer Metastasis Reviews|October 17, 2014
Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive systemAnsgar Brüning, Thomas Blankenstein, Julia Jückstock, et al.The Journal of Clinical Investigation|January 26, 2016
Targeting human melanoma neoantigens by T cell receptor gene therapyMatthias Leisegang, Thomas Kammertoens, Wolfgang Uckert, et al.Transgenic Research|December 15, 2011
Depot formation of doxycycline impairs Tet-regulated gene expression in vivoKathleen Anders, Christian Buschow, Jehad Charo, et al.Pageof 15